V. Viswanathan, Mangesh M. Londhe, Aakriti Kundlia, Yamini Ingale
{"title":"Utility of EUS-Guided FNAC in the Diagnosis of Spindle Cell Lesion of the GI Tract: A Case Report","authors":"V. Viswanathan, Mangesh M. Londhe, Aakriti Kundlia, Yamini Ingale","doi":"10.4103/mjdrdypu.mjdrdypu_808_23","DOIUrl":null,"url":null,"abstract":"ABSTRACT\n \n Gastrointestinal (GI) tumors pose a diagnostic challenge due to their diverse histology and location. EUS was first used clinically in 1980. Since its inception, it has emerged as a valuable diagnostic tool for GI lesions, to a versatile therapeutic modality, encompassing a wide range of indications. EUS faces challenges in distinguishing benign from malignant lesions. The partnership between cytopathologists and endoscopists, coupled with rapid on-site evaluation (ROSE), has become crucial in patient management. Recent technical advancements along with the addition of FNAC have greatly increased its diagnostic accuracy. Endoscopic ultrasonography-guided fine-needle aspiration cytology (EUS-FNAC) has become a routine practice in many healthcare facilities, aiding in the diagnosis of mediastinal, GI, and pancreatic malignancies. EUS-FNAC offers several advantages, such as multi-site aspiration and lower cost as compared to other procedures. Even its potential in the area of molecular studies has been recently investigated. In this case study, a 45-year-old man who underwent EUS-FNAC is presented. The combination of histology, immunohistochemistry, and EUS-FNAC allowed us to make a conclusive diagnosis of GI stromal tumors (GIST).","PeriodicalId":18412,"journal":{"name":"Medical Journal of Dr. D.Y. Patil Vidyapeeth","volume":"203 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Journal of Dr. D.Y. Patil Vidyapeeth","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/mjdrdypu.mjdrdypu_808_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
ABSTRACT
Gastrointestinal (GI) tumors pose a diagnostic challenge due to their diverse histology and location. EUS was first used clinically in 1980. Since its inception, it has emerged as a valuable diagnostic tool for GI lesions, to a versatile therapeutic modality, encompassing a wide range of indications. EUS faces challenges in distinguishing benign from malignant lesions. The partnership between cytopathologists and endoscopists, coupled with rapid on-site evaluation (ROSE), has become crucial in patient management. Recent technical advancements along with the addition of FNAC have greatly increased its diagnostic accuracy. Endoscopic ultrasonography-guided fine-needle aspiration cytology (EUS-FNAC) has become a routine practice in many healthcare facilities, aiding in the diagnosis of mediastinal, GI, and pancreatic malignancies. EUS-FNAC offers several advantages, such as multi-site aspiration and lower cost as compared to other procedures. Even its potential in the area of molecular studies has been recently investigated. In this case study, a 45-year-old man who underwent EUS-FNAC is presented. The combination of histology, immunohistochemistry, and EUS-FNAC allowed us to make a conclusive diagnosis of GI stromal tumors (GIST).